FADS2 and inflammatory bowel disease: Clear differences in FADS2 haplotypes across ancestries have been proposed to explain variable results in clinical trials involving ω3 fatty acid supplements [25], and dietary shifts may feasibly contribute to population differences in the rates of increase in IBD prevalence [26].